China National Accord Medicines Corporation Ltd. (200028.SZ)
HKD 11.5
(-0.26%)
HKD 11.5
(-0.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 75.47 Billion | 73.44 Billion | 68.35 Billion | 59.64 Billion | 52.04 Billion | 43.12 Billion |
| Cost of Revenue | 66.42 Billion | 64.51 Billion | 60.33 Billion | 52.59 Billion | 46.29 Billion | 38.02 Billion |
| Gross Profit | 9.05 Billion | 8.92 Billion | 8.01 Billion | 7.05 Billion | 5.75 Billion | 5.09 Billion |
| Operating Expenses | 6.53 Billion | 6.51 Billion | 5.86 Billion | 5.03 Billion | 3.99 Billion | 3.63 Billion |
| Selling, General and Administrative Expenses | 6.48 Billion | 5.47 Billion | 4.93 Billion | 4.14 Billion | 3.22 Billion | 2.91 Billion |
| Research and Development Expenses | 26.82 Million | 9.06 Million | 7.74 Million | - | - | - |
| Other Expenses | 32.1 Million | 1.03 Billion | 928.26 Million | 891.45 Million | 763.07 Million | 7.95 Million |
| Cost and Expenses | 73.01 Billion | 71.03 Billion | 66.2 Billion | 57.62 Billion | 50.28 Billion | 41.66 Billion |
| Operating Income | 2.46 Billion | 2.3 Billion | 1.95 Billion | 2.16 Billion | 1.83 Billion | 1.67 Billion |
| Interest Expense | 248.38 Million | 261.9 Million | 288.03 Million | 258.18 Million | 271.71 Million | 195.25 Million |
| Income Tax Expense | 514.73 Million | 539.33 Million | 447.21 Million | 435.94 Million | 372.43 Million | 330.49 Million |
| Earnings before Tax | 2.47 Billion | 2.31 Billion | 1.97 Billion | 2.15 Billion | 1.85 Billion | 1.67 Billion |
| Net Income | 1.59 Billion | 1.48 Billion | 1.33 Billion | 1.4 Billion | 1.27 Billion | 1.21 Billion |
| Earnings Per Share Basic | 2.87 | 3.47 | 2.40 | 2.52 | 2.28 | 2.18 |
| Earnings Per Share Diluted | 2.87 | 3.47 | 2.40 | 2.52 | 2.28 | 2.18 |
| Weighted Average Shares Outstanding | 557.23 Million | 428.44 Million | 556.56 Million | 556.56 Million | 556.56 Million | 556.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 556.56 Million | 428.44 Million | 556.84 Million | 557.32 Million | 556.86 Million | 556.17 Million |
| Gross Margin | 0.12 | 0.12 | 0.12 | 0.12 | 0.11 | 0.12 |
| EBIT Margin | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 |
| Profit Margin | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| EBITDA | 4.14 Billion | 3.88 Billion | 3.53 Billion | 3.47 Billion | 2.94 Billion | 1.53 Billion |
| Earnings Before Tax Margin | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 18.68 Billion | 18.69 Billion | 19.09 Billion | 18.89 Billion | 75.47 Billion | 18.19 Billion |
| Cost of Revenue | 16.68 Billion | 16.62 Billion | 17.01 Billion | 16.37 Billion | 66.42 Billion | 16.11 Billion |
| Gross Profit | 1.99 Billion | 2.06 Billion | 2.07 Billion | 2.51 Billion | 9.05 Billion | 2.08 Billion |
| Operating Expenses | 1.58 Billion | 1.68 Billion | 1.54 Billion | 1.8 Billion | 6.55 Billion | 1.55 Billion |
| Selling, General and Administrative Expenses | 3.36 Billion | 1.21 Billion | 1.51 Billion | 862.21 Million | - | 1.96 Billion |
| Research and Development Expenses | 6.27 Million | 6.7 Million | 6.26 Million | 8.86 Million | - | 5.92 Million |
| Other Expenses | -1.78 Billion | 2.86 Million | 6.24 Million | 8.27 Million | 5.8 Million | -16.44 Million |
| Cost and Expenses | 18.26 Billion | 18.31 Billion | 18.56 Billion | 18.17 Billion | 72.97 Billion | 17.66 Billion |
| Operating Income | 395.58 Million | 404.85 Million | 544 Million | 644.5 Million | 2.46 Billion | 527.8 Million |
| Interest Expense | 67.46 Million | 76.33 Million | 54.74 Million | 64.86 Million | 248.38 Million | 75.26 Million |
| Income Tax Expense | 72.87 Million | 83.78 Million | 104.12 Million | 144.48 Million | 514.73 Million | 108 Million |
| Earnings before Tax | 398.49 Million | 407.71 Million | 550.24 Million | 652.77 Million | 2.47 Billion | 528.79 Million |
| Net Income | 322.05 Million | 354.71 Million | 388.77 Million | 409.59 Million | 1.59 Billion | 359.41 Million |
| Earnings Per Share Basic | 0.63 | 0.69 | 0.70 | 0.73 | - | 0.65 |
| Earnings Per Share Diluted | 0.63 | 0.69 | 0.70 | 0.73 | - | 0.65 |
| Weighted Average Shares Outstanding | 556.56 Million | 556.56 Million | 555.38 Million | 561.12 Million | 557.23 Million | 553.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 556.56 Million | 556.56 Million | 555.38 Million | 558.5 Million | 556.56 Million | 553.32 Million |
| Gross Margin | 0.11 | 0.11 | 0.11 | 0.13 | 0.12 | 0.11 |
| EBIT Margin | 0.02 | 0.03 | 0.03 | 0.04 | - | 0.03 |
| Profit Margin | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| EBITDA | 465.96 Million | 494.72 Million | 649.59 Million | 749.8 Million | - | 621.81 Million |
| Earnings Before Tax Margin | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 |
601139
HMVL
IBOC
OBCN
OASMY
ITHUF